Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II

Background: Krebs von den Lungen-6 (KL-6) has been proposed as a disease severity marker of COVID-19. All research articles reported the KL-6 assay detected through Fujirebio reagents by Lumipulse G600/G1200 instrument. In the present study, KL-6 assay was analysed through Tosoh AIA-360 and compared...

Descripción completa

Detalles Bibliográficos
Autores principales: d’Alessandro, Miriana, Bergantini, Laura, Cavallaro, Dalila, Gangi, Sara, Cameli, Paolo, Conticini, Edoardo, Frediani, Bruno, Dotta, Francesco, Bargagli, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8872393/
https://www.ncbi.nlm.nih.gov/pubmed/35206372
http://dx.doi.org/10.3390/ijerph19042176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8872393/
https://www.ncbi.nlm.nih.gov/pubmed/35206372
http://dx.doi.org/10.3390/ijerph19042176

Ejemplares similares